Mr. Stamoran will be on the panel titled “Drilling Down: New Jersey Life Sciences Community.” As New Jersey's life sciences industry has grown into the greatest cluster of pharmaceutical, biotech and medical technology companies in the world, specialized companies providing technologies and services have also evolved. This panel will examine the critical role these companies play in the industry and their future role in the changing life sciences business model.
Mr. Stamoran has more than 20 years of experience in the pharmaceutical industry. Since joining Catalent in 1992, he has held many roles across a variety of disciplines. During his career, Mr. Stamoran has directly participated in the development of patient adherence and outcomes enhancement strategies for more than 150 innovator drugs.
Mr. Stamoran holds a B.S. degree in accounting and management from the University of Michigan. He is also a certified public accountant, a certified management accountant, a certified information systems auditor, and a certified licensing professional. Besides being a member of the Association for CorporateGrowth, the National Investor Relations Institute, the Society of Competitive Intelligence Professionals, and the World Futures Society, Mr. Stamoran also has published articles in a variety of pharmaceutical publications. He has also served as a conference chairman, board member and speaker for several industry conferences.
Companies in this article